Mitochondrial genetics

Nov 19, 2019

Stealth Biotherapeutics to Present at Jefferies 2019 London Healthcare Conference

Nov 11, 2019

Stealth Biotherapeutics to Report Third Quarter 2019 Financial Results on Thursday, November 14, 2019

Oct 16, 2019

Mitochondrial Disease Therapies Market, 2019-2030

Oct 07, 2019

Stealth BioTherapeutics Presents Data on SBT-272 in Neurodegeneration

Oct 01, 2019

Stealth Biotherapeutics to Present at the 2019 Cantor Global Healthcare Conference

Sep 20, 2019

Stealth BioTherapeutics to Attend Upcoming Investor Conferences

Sep 03, 2019

Stealth BioTherapeutics Announces Appointment of Robert Weiskopf as Chief Financial Officer

Feb 07, 2019

Maintaining the Utility of Stem Cells in Tissue Engineering

Jun 21, 2018

Leading mitochondrial DNA researcher discusses causes of common complex diseases at Feinstein Institute Marsh Lecture

Apr 26, 2018

Mode of Action of the Mitochondrial Clinical-stage Drug Candidate Kh176: Two Birds, One Stone

Nov 30, 2017

NeuroVive's Genetic Mitochondrial Disease Program NVP015 Reaches Significant Milestone

Nov 16, 2017

Khondrion Will Present First Results of KHENERGY Study

Aug 23, 2017

Altered Mitochondria Associated with Increased Autism Risk